European Antibody Congress 2018

Egotumab, a human antibody against colorectal cancer, to be presented Wednesday 31.10.2018 at 9:30 am in Basel, Switzerland.

 

Meet us at the conference. 


Logo

Logo

Logo

 

 

Logo

LogoBaseLaunch selected Cureab for phase I of its accelerator program in September 2018.

                                                                                 We highly appreciate their trust in us.

About the program:

Baselaunch provides non-dilutive funding, no strings attached access to its Healthcare Partners and knowledge from highly experienced advisors. Furthermore, Baselaunch embeds selected ventures deeply within the Basel region, one of Europe’s finest biotech ecosystem.

 

Logo